Rensselaer professor Shawn-Yu Lin named Fellow of the AAAS

( Rensselaer Polytechnic Institute ) Nano-photonics expert Shawn Yu-Lin, professor of physics at Rensselaer Polytechnic Institute and a member of the university's Future Chips Constellation and Smart Lighting Engineering Research Center, has been selected as a fellow of the American Association for the Advancement of Science.

Read this article:

Rensselaer professor Shawn-Yu Lin named Fellow of the AAAS

Police news: Twice as many helmeted motorcyclists crash since law repeal, kids pair with emergency responders during …

More than 30 children received a $100 shopping spree with a Genesee County emergency responder to keep them company as part of the store's Shop with a Hero program, Dec. 4, 2012. Griffin Moores | MLive.com FLINT, MI --...

See original here:

Police news: Twice as many helmeted motorcyclists crash since law repeal, kids pair with emergency responders during ...

Invivoscribe Launches Genection, a New Personalized Molecular Medicine Company Delivering Global Access to the Entire …

SAN DIEGO, CA--(Marketwire - Dec 4, 2012) - Invivoscribe Technologies, Inc., a privately-held life science company based in San Diego, California, announces the launch of Genection, Inc.

Genection provides physicians with a dedicated online platform for global access to the entire clinically-actionable genetic test menu, including both routine and esoteric genetic tests, exome and whole genome sequencing, cancer somatic mutation testing, and pharmacogenomics.

Genection's model is not payor driven, so prescribing physicians have access to genetic tests that may currently be unavailable, overlooked, or even inaccessible through their patients' managed care plans and health care institutions. Combine this comprehensive genetic test offering with convenient online ordering, seamless linking of multiple CLIA and CAP accredited laboratories for reporting and interpretation and integrated service offerings such as next generation sequencing and advanced bioinformatics in a singular location and Genection is streamlining the entire diagnostic pipeline.

"Genection is a valuable tool in the personalized molecular medicine landscape. Clinicians spend too much of their time identifying and ordering clinically relevant genetic tests, while struggling to keep abreast of the flood of clinical information around new biomarkers," said Bradley Patay, M.D., Genection's Chief Medical Officer. "In addition to thebroad selectionof genetic tests available to order through their service, Genection offers one of the most relevant new genomic testing servicesnext generation sequencing used to detect driver mutations in cancer."Oncologists appreciate that current more effective and individualized cancer treatment programs require improved diagnostic stratification of their patients. Using targeted gene assays for deep sequencing of oncogenes and tumor suppressor genes, and exome sequencing to identify rare or unknown genes that may contribute to an individual's cancer, an oncologist can better identify the underlying cause of a patient's tumor to create a more targeted treatment plan.

Genection has agreements in place with several top CLIA and CAP accredited laboratories as well as sequencing centers."Our initial partners include ARUP Laboratories, Foundation Medicine, Cypher Genomics, the Laboratory for Personalized Molecular Medicine (LabPMM) in the U.S., as well as its ISO15189 compliant laboratory (LabPMM GmbH) in Martinsried, Germany," said Suzanne Graham, Genection's Senior Manager of Business Development. "Genection also has established relationships with sequencing providers, including Illumina and Ambry Genetics." Moreover, Genection has alliances with a consortium of genetic counselors, to provide current informed decision making support, reducing costs of the informed consent process, and helping to avoid unnecessary testing.

What does this integration mean for a physician and their patient?

"In order to make personalized molecular medicine a clinical reality, new platforms need to be developed for the delivery of healthcare.Genection's mission seeks to accelerate this adoption process," Dr. Patay continued. "The combination of CLIA-validated genetic testing, whole exome or whole genome sequencing and broad targeted assays, along with critical bioinformatics, analytic tools, and interpretative guidelines will contribute to timely definitive diagnoses for patients with rare, unexplained diseases or complex diseases; in essence, this integration will speed delivery of genomic test results and improve patient care."

More than just facilitating ordering and transmitting patient reports and data, Genection's service is designed to vastly improve the communication between genetic counselors, physicians and patients. The Genection web application provides HIPAA compliant, secure patient data management for physicians and health organizations. As patient care moves to more team-based management, it is vital for patient information to integrate with several clinicians, and not be limited to one single provider.Genection streamlines this process, allowing clinicians to share test results and genetic information with other healthcare providers, which can assist in a diagnosis for a patient and accelerate creation of individualized treatment plans and potentially life-saving therapies.

Genection also serves as the gateway for the global Together We Cure initiative, which allows acute myeloid leukemia (AML) patients and physicians to share clinical information to facilitate more rapid development of AML targeted therapeutics.

Genection is a privately held company owned by Invivoscribe Technologies, Inc., founded 18 years ago by its Chairman & CEO, Jeffrey E. Miller, Ph.D.Dr. Miller will serve as President of Genection.Bradley A. Patay, MD is Genection's Chief Medical Officer, and Suzanne M. Graham, Ph.D., is Senior Manager of Business Development.

Read more from the original source:

Invivoscribe Launches Genection, a New Personalized Molecular Medicine Company Delivering Global Access to the Entire ...

Metabolic biomarkers for preventive molecular medicine

( Centro Nacional de Investigaciones Oncologicas (CNIO) ) A team of scientists from the Spanish National Cancer Research Centre, led by its director, María Blasco, together with Jose M. Mato, the director of the Center for Cooperative Research in Biosciences, has shown that the metabolic profile of an organism indicates its level of cellular aging and the general state of health in mice.

Visit link:

Metabolic biomarkers for preventive molecular medicine

Phoenix Children's Hospital Creating $50M Molecular Medicine Institute

NEW YORK (GenomeWeb News) – Phoenix Children's Hospital said today that it has launched a new molecular and personalized medicine research institute, working with the and other partners, that will focus first on childhood cancers but later will branch out into other research directions.

See the original post here:

Phoenix Children's Hospital Creating $50M Molecular Medicine Institute

Mary McNaughton-Collins Discusses Breast Cancer Overdiagnosis – Video


Mary McNaughton-Collins Discusses Breast Cancer Overdiagnosis
Mary McNaughton-Collins, medical director at the Informed Medical Decisions Foundation, provides her take on a recent New England Journal of Medicine paper titled "Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence." The authors of this paper came to the startling conclusion that roughly 1.3 million women in the last three decades have been overdiagnosed with breast cancer.From:FIMDMViews:0 0ratingsTime:02:46More inNonprofits Activism

See the rest here:

Mary McNaughton-Collins Discusses Breast Cancer Overdiagnosis - Video

Memory Research – Video


Memory Research
Steven Laviolette of Western University #39;s Schulich School of Medicine Dentistry and PhD Candidate Nicole Lauzon have identified a mechanism in a region of the brain which can block obtrusive memories associated with post-traumatic stress syndrome or drug addiction.From:WesternUniversityViews:4 0ratingsTime:01:58More inEducation

Original post:

Memory Research - Video

GoodNights Christmas Celebration 2012 – GwAzAi Promo #1 – Video


GoodNights Christmas Celebration 2012 - GwAzAi Promo #1
DJ MRI in Conjunction with Goodworks Present GOODNIGHTS *Christmas Celebration*!!! - A Night of Good Vibes and Good Music - #9553; #9679; bull; #9679; Live Band || Salsa #9553; Comedy || Christmas Karaoke Open Mic || AfterParty till late #9679; bull; #9679; #9553; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; SUNDAY 23RD DECEMBER 2012 @ #9733; WATER MARGIN O2 #9733; The O2, 23 Entertainment Avenue, Greenwich, London, SE10 0DY Host: Simply Andy Artists: GwAzAi, Kersha Bailey SO Directions: Bus 108(24h), 129, 132, 161, 188(24h), 422, 472(24h), 486 Nearest Station : North Greenwich Parking in the NCP car park 3 all day Sunday. Doors Open 7PM, show starts at 8PM AfterParty till late!!! DressCode: Smart Sophisticated... (hint of RED...) No Baseball Hats, Hoodies or Sportswear... 18+ Please bring your ID. #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9553; #9679; bull; #9679; A NIGHT NOT TO BE MISSED #9679; bull; #9679; #9553; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; SALSA TIME with Live Band!!! Come early to participate in the latin phenomenon that is Salsa! #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; COMEDY!!! "Laughter is good medicine", they say. #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9776; CHRISTMAS KARAOKE with Live Band #9776; Come ready to sing your favourite Christmas Classics. #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9835; #305;l #305;ll| #818; #773; #773; #9679; #818; #773; #773;| #818; #773; #773;= #818; #773; #773;| #818; #773; #773;|ll #305;l #305; AFTERPARTY WITH DJ MRI #305;l #305;ll| #818; #773; #773; #9679; #818; #773; #773;| #818; #773; #773;= #818; #773; #773;| #818; #773; #773;|ll #305;l #305; #9835; #9835; #9835;Playing the BEST R B, HIP HOP, AFROBEATS HOUSE #9835; #9835; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9600; #9776; SPECIAL OFFERS #9776; *Early Bird ...From:DjMriViews:2 0ratingsTime:00:27More inNonprofits Activism

Read the rest here:

GoodNights Christmas Celebration 2012 - GwAzAi Promo #1 - Video

Emotional Activation from Theory to Practice – Video


Emotional Activation from Theory to Practice
Yves Furet and Daniel Baumgartner, partners at LeadX, introduce the Betaferon case: possibly the clearest piece of evidence that the emotional-activation approach works in the pharmaceutical world. Betaferon is the first ever multiple sclerosis medicine. Some years after launch, sales were stagnating and market share was suffering. The product was then filled with emotions: the paradigm was shifted - attention was placed on patients #39; empowerment. Sales skyrocketed (an increase of 10% achieved in only 6 months). Certainly an interesting case study for all interested in pharma industry management and emotional activation.From:Stefano DavanzoViews:0 0ratingsTime:03:25More inPeople Blogs

More here:

Emotional Activation from Theory to Practice - Video